HAVE YOU SUFFERED FROM HEART FAILURE OR PANCREATITIS AFTER TAKING ONGLYZA?
Onglyza (saxagliptin) is a medication prescribed to treat type 2 diabetes, either as a singular therapy or in combination with other drugs. Saxagliptin was co-developed by Bristol-Myers Squibb and AstraZeneca in 2007. The drug was marketed and released as Onglyza in 2008. Onglyza is an oral diabetes medication of the DPP-4 inhibitor class. DPP-4 inhibitors work by blocking an enzyme that destroys incretin, a hormone responsible for producing insulin when the body needs it and reducing glucose levels in the liver when it is not needed.
Common symptoms of Onglyza include:
- Upper respiratory tract infection
- Urinary tract infection
- Joint pain
- Skin reactions (bulbous pemphigoid)
- Swelling of hands, feet, or ankles
Unfortunately, Onglyza has several more dangerous side effects that could prove to be fatal if left untreated or undiagnosed.
ONGLYZA, DPP-4 INHIBITORS MAY CAUSE INCREASED RISK OF HEART FAILURE
The United States Food and Drug Administration (FDA) issued a safety warning regarding type 2 diabetes medications containing saxagliptin and alogliptin. The agency warned that the medications may increase the risk of heart failure, especially in patients with heart or kidney disease. In 2016, medications containing saxagliptin and alogliptin added this warning to their labels.
Patients taking Onglyza or other DPP-4 inhibitor medications are urged to watch for the signs and symptoms of heart failure, including:
- Unusual shortness of breath
- Trouble breathing
- Weight gain and swelling of the extremities or stomach
TYPE 2 DIABETES DRUGS LINKED TO INCREASED RISK OF PANCREATITIS
Another serious side effect associated with Onglyza is inflammation of the pancreas, or pancreatitis. Certain factors can further increase your risk of developing pancreatitis while taking Onglyza, such as having previous pancreatitis, gallstones, high blood triglyceride levels, or a history of alcoholism.
If you develop a severe pain in your stomach after taking Onglyza, it may be a sign of pancreatitis and your healthcare provider should be notified immediately.
CONTACT AN EXPERIENCED DANGEROUS DRUG ATTORNEY
Diabetes medications like Onglyza are prescribed to people suffering from type 2 diabetes and are looking for a better quality of life. When these drugs, oftentimes pushed and marketed as safe, instead harm diabetes patients, the pharmaceutical companies must pay. Every year, millions of people are put at risk when taking dangerous drugs because these companies put profit before safety. If you have developed heart failure or pancreatitis after taking Onglyza, contact Thomas J. Henry. Our experienced dangerous drug lawyers are available 24/7, nights and weekends to evaluate your claim.